Gland Pharma gains over 2% after USFDA clears Telangana manufacturing facility

Gland Pharma Ltd shares gained almost 3% on Thursday after the company announced receiving a Good Manufacturing Practice (GMP) certification from the United States Food and Drug Administration (USFDA) for its facility in Hyderabad.

Leave a Reply

Your email address will not be published. Required fields are marked *